 Journey Medical Corporation NASDAQ: DERM has acquired Molecule Stabilizing Technology MST franchise, including Amzeeq minocycline topical foam and Zilxi minocycline topical foam from VYNE Therapeutics Inc NASDAQ: VYNE The transaction includes cash payments of 25 million and potential milestones of up to 450 million. 